Handgrip strength asymmetry as a new biomarker for sarcopenia and individual sarcopenia signatures.
Jedd PrattLudmilla PessanhaMarco NariciColin BorehamGiuseppe De VitoPublished in: Aging clinical and experimental research (2023)
Our findings demonstrate the utility of HGS asymmetry as a screening tool that may complement existing strategies seeking to combat sarcopenia. Biomarker analyses suggest that heightened denervation may be an important aetiological factor underpinning HGS asymmetry.